Disproportionality analysis of pyoderma gangrenosum reporting to the FDA Adverse Event Reporting System in association with antirheumatic biologics

Clinical Rheumatology 2026

View at publisher

Authors: Richard H. Woods

DOI: 10.1007/s10067-026-08237-1

Cited by: 1

References: 23

Fields of Study & Subjects

Autoimmune and Inflammatory Disorders Hidradenitis Suppurativa and Treatments Drug-Induced Adverse Reactions

References 23